Very recently, a study demonstrated that MARCH1 was aberrantly overexpressed in ovarian cancer tissues and that knockdown of MARCH1 expression inhibited the progression of ovarian cancer cells via the downregulation of the NF-κB and Wnt/β-catenin pathways [19]. The gene discussed is MARCHF1; the disease is ovarian cancer.